AdAlta presentation at Bioshares Biotech Summit

AdAlta Limited (ASX:1AD), the clinical stage biotechnology company developing novel therapeutic products from its i-body platform, is pleased to advise that CEO and Managing Director, Dr Tim Oldham, will be presenting at the 16th Bioshares Biotech Summit in Albury, NSW on 11 May 2022.

The Bioshares Biotech Summit’s unique format brings together biotechnology companies and equity capital markets participants to explore not just what biotechnology companies do but just as importantly how they do it. In keeping with this purpose, Dr Oldham’s presentation will focus on how AdAlta makes big strategic and portfolio decisions to guide development of its i-body drug discovery platform, including a case study of the decision in 2021 to add an intravenous formulation of AD-214 to enhance the convenience and cost effectiveness of the product.